What is the recommended detailed management of an acute gout attack?

Management of Acute Gout Attack

Treat acute gout attacks as early as possible with first-line options including low-dose colchicine (1 mg followed by 0.5 mg one hour later if started within 12 hours), NSAIDs with proton pump inhibitor, or oral corticosteroids (30-35 mg/day prednisolone equivalent for 3-5 days), selecting based on contraindications and patient comorbidities. 1

Immediate Treatment Approach

First-Line Pharmacologic Options

The EULAR guidelines provide three equally effective first-line options for acute gout flares 1:

• Low-dose colchicine: 1 mg loading dose followed by 0.5 mg one hour later on day 1, but ONLY if initiated within 12 hours of symptom onset 1

  • This low-dose regimen (total 1.8 mg) is as effective as high-dose colchicine (4.8 mg) but with significantly fewer gastrointestinal side effects 2, 1
  • The American College of Physicians similarly recommends this low-dose regimen (1.2 mg followed by 0.6 mg one hour later) 2

• NSAIDs with gastroprotection: Any NSAID at full anti-inflammatory doses plus proton pump inhibitor if appropriate 1

  • No specific NSAID is superior to another; indomethacin has no advantage over naproxen or ibuprofen 2
  • The key to success is early initiation, not which specific NSAID is chosen 3

• Oral corticosteroids: 30-35 mg/day prednisolone equivalent for 3-5 days 1

  • Equivalent efficacy to NSAIDs based on randomized trials 1, 4

Patient Education for Self-Management

Educate patients to self-medicate at the first warning symptoms using a "pill in the pocket" approach 1. This strategy maximizes treatment effectiveness, as early initiation is the most important determinant of therapeutic success 3.

Selecting Treatment Based on Contraindications

Critical Contraindications to Consider

Severe renal impairment 1:

• Avoid both colchicine and NSAIDs in patients with severe renal impairment 1
• Use oral or intra-articular corticosteroids instead 1

Drug interactions with colchicine 1:

• Do NOT give colchicine to patients receiving strong P-glycoprotein and/or CYP3A4 inhibitors (cyclosporin, clarithromycin) 1
• Reduce colchicine dose in patients on statins due to risk of neurotoxicity and muscular toxicity 1

NSAID contraindications 2:

• Avoid in patients with renal disease, heart failure, or cirrhosis 2
• Risk of gastrointestinal perforations, ulcers, and bleeding 2

Alternative Approaches

Intra-articular corticosteroid injection: Consider articular aspiration and injection of corticosteroids, particularly for monoarticular involvement 1

Combination therapy: For severe acute gout involving multiple joints, consider combining colchicine with an NSAID or colchicine with corticosteroids 1

Second-Line Treatment for Refractory Cases

IL-1 blockers (such as canakinumab) should be considered for patients with frequent flares who have contraindications to colchicine, NSAIDs, and corticosteroids 1, 4. Current infection is an absolute contraindication to IL-1 blocker use 1.

Critical Pitfalls to Avoid

Do NOT initiate or adjust urate-lowering therapy during an acute attack 2. The American College of Physicians strongly recommends against initiating long-term urate-lowering therapy during acute flares 2. If a patient is already on urate-lowering therapy, continue it at the same dose 1.

Timing matters critically for colchicine: The 12-hour window for colchicine effectiveness is evidence-based; beyond this timeframe, efficacy diminishes significantly 1.

Avoid high-dose colchicine: The older high-dose regimen (1.2 mg followed by 0.6 mg every hour for 6 hours) causes significantly more gastrointestinal adverse effects without additional benefit 2.

Comprehensive Patient Assessment

Screen for Comorbidities

Every patient with gout should be systematically screened for 1:

• Renal impairment: Calculate estimated glomerular filtration rate (eGFR) at diagnosis and monitor regularly 1
• Cardiovascular risk factors: Coronary heart disease, heart failure, stroke, peripheral arterial disease 1
• Metabolic conditions: Obesity, hyperlipidemia, hypertension, diabetes 1

These comorbidities directly influence treatment selection and are independent risk factors for adverse outcomes 1.

Lifestyle Modifications

Provide specific advice on 1:

• Weight loss if appropriate 1
• Avoid: Alcohol (especially beer and spirits), sugar-sweetened drinks, heavy meals, excessive meat and seafood intake 1
• Encourage: Low-fat dairy products and regular exercise 1